Linklaters has advised the EIC Fund on its participation in the €6.3 million Series A equity funding round of Antofénol SAS. The EIC Fund has invested alongside the Caisse des Dépôts et Consignations (CDC), ERPIM, EIT Food and other new and existing investors.
Antofénol is a French-based company specialised in the design and production of eco-extraction solutions and other solutions for use in cosmetics, nutraceutical and biocontrol, developing a range of natural, eco-conscious and anti-microbial products derived from agricultural waste.
Established in June 2020, the EIC Fund is a breakthrough initiative of the European Commission to make direct equity and quasi-equity investments (between €500,000 and €15m) in European high impact and deep tech start-ups and scale ups.
Linklaters recently advised the EIC Fund on its investments in Minuendo AS, Demeta SAS, Lixea OÜ, Hiber B.V., EpiEndo Pharmaceuticals ehf., NIL Technology ApS and Corwave SA.
The Linklaters team was led by Darko Adamovic, Partner, Energy & Infrastructure and Mehdi Boumedine, Counsel, Corporate with Margaux Sartre, Associate, Corporate.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
